| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |